Are there targeted drugs for gastric cancer treatment?

Are there targeted drugs for the treatment of gastric cancer?

Gastric cancer targeted drugs include anti-HER2 gene drugs, including trastuzumab. When the anti-HER2 gene is positive, chemotherapy can be combined with trastuzumab to increase the effect of chemotherapy. There are also anti-EGFR gene therapy drugs. Such as apatinib and ramucirumab, which are immune targeted drugs for the third-line treatment of advanced gastric cancer.

1. Targeted drugs for gastric cancer include trastuzumab, etc.: Anti-HER2 gene and other therapeutic drugs include trastuzumab. When the HER2 gene is positive during treatment, it can be combined with trastuzumab to increase the chemotherapy effect of the patient; anti-EGFR and other gene drugs, such as apatinib, are generally used for advanced gastric cancer and adopt third-line standard treatment.

2. Ramucirumab: It is an anti-angiogenic drug that blocks the intake of oxygen and nutrients, reduces tumors and causes them to die. The main target of this drug is VEGFR. It does not require genetic testing when used and can be used directly, with good results.

3. Apatinib: Apatinib is a multi-targeted small molecule targeted drug developed in China and has been approved by the FDA for use after failure of second-line chemotherapy for gastric cancer.

The above mentioned are the types of targeted drugs used to treat gastric cancer, including apatinib, etc. The use of immune targeted therapy drugs, ramucirumab, trastuzumab, etc. have good therapeutic effects. When one of the drugs is not very effective, other drugs can also be used for treatment. There are many such targeted drugs.